CSL
Carlisle Companies Incorporated
CSL has the edge over RKLB overall, supported by lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CSL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
CSL's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CSL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $258 | -34% |
| Forward | 17x | $393 | — |
| Fair | 20x | $351 | -11% |
| Current | 22x | $393 | — |
| Expensive | 26x | $459 | +17% |
Historical ranges are pointers, not guarantees.
CSL's PE is in its expensive range at 22x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CSL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CSL, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CSL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $23.69 | +34% |
| Q3 2026 | $17.70 | -0.7% |
| Q2 2026 | $17.44 | -3.6% |
| Q1 2026 | $17.02 | -37% |
| Q4 2025 | $17.12 | -38% |
| Q3 2025 | $17.82 | -37% |
| Q2 2025 | $18.09 | -36% |
| Q1 2025 | $27.05 | +57% |
| Q4 2024 | $27.82 | +83% |
CSL has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CSL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +8.6% |
| Q2 2026 | $1.6B | +8.3% |
| Q1 2026 | $1.1B | -4% |
| Q4 2025 | $1.1B | +0.4% |
| Q3 2025 | $1.3B | +1% |
| Q2 2025 | $1.4B | -0.1% |
| Q1 2025 | $1.1B | -0.1% |
| Q4 2024 | $1.1B | -0.4% |
CSL's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -1.8 points |
| Q2 2026 | 22% | -0.7 points |
| Q1 2026 | 17% | +0.4 points |
| Q4 2025 | 17% | -3.1 points |
| Q3 2025 | 22% | -1.9 points |
| Q2 2025 | 23% | -2.9 points |
| Q1 2025 | 17% | -3.8 points |
| Q4 2024 | 20% | -2.5 points |
CSL has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CSL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CSL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $277.3M | -30% |
| Q2 2026 | $200.1M | -23% |
| Q1 2026 | -$73M | -$45.8M |
| Q4 2025 | $346.1M | +3.6% |
| Q3 2025 | $393.4M | +34% |
| Q2 2025 | $258.3M | +63% |
| Q1 2025 | -$27.2M | -121% |
| Q4 2024 | $334M | -5.4% |
CSL has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CSL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -900K shares |
| 1 year | -7.7% | -3.3M shares |
| 3 years | -21% | -10.5M shares |
| 5 years | -25% | -13.4M shares |
| Available history | -31% | -17.9M shares |
CSL has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $350M |
| Q2 2026 | $250M |
| Q1 2026 | $250M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q2 2025 | $300M |
| Q1 2025 | $400M |
| Q4 2024 | $419.8M |
CSL spent $1.1B buying back its own shares over the past year, down 19% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CSL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 0.9x | Very low |
CSL's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CSL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.2 | Neutral |
| Stochastic | 76.1 | Neutral |
CSL's weekly RSI is 61 (neutral) and its Stochastic is 76 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CSL PE vs Industrials Sector
| Metric | CSL | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 24x | 7.9% below |
| PE % | 67 | 58 | 9 pts above |
CSL is trading at 22x earnings, in line with the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CSL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $350.0 | 12% above |
| 20 week MA | $351.1 | 12% above |
| 50 week MA | $352.1 | 11% above |
| 100 week MA | $357.0 | 10% above |
| 200 week MA | $341.9 | 15% above |
CSL has the edge over RKLB on trend strength, trading above more of its moving averages.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
CSL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $163.0 | $157.4 | -3.5% |
| 2021 | $157.4 | $240.8 | +53% |
| 2022 | $240.8 | $237.9 | -1.2% |
| 2023 | $237.9 | $312.4 | +31% |
| 2024 | $312.4 | $372.0 | +19% |
| 2025 | $372.0 | $330.3 | -11% |
| 2026 YTD | $330.3 | $392.6 | +19% |
CSL has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.